Wednesday, 20 Aug 2008 | Source: The Associated Press
PDL BioPharma Inc.'s stock gained ground Wednesday after pharma giant Bristol-Myers Squibb Co. signed a deal to license the biotechnology company's developing blood cancer drug.
Wednesday, 20 Aug 2008 | Source: The Associated Press
Among the stock activity stories for Wednesday, Aug. 20, from AP Financial News:
Tuesday, 19 Aug 2008 | Source: The Associated Press
Drugmaker Bristol-Myers Squibb Co. said Tuesday it will pay $30 million to acquire rights to an experimental treatment for blood cancer from PDL BioPharma Inc.
Tuesday, 12 Aug 2008 | Source: The Associated Press
PDL BioPharma Inc. said late Monday its chief scientific officer, Richard Murray, will resign to pursue other interests.
Tuesday, 12 Aug 2008 | Source: The Associated Press
PDL BioPharma Inc. said late Monday its second-quarter profit surged on higher royalty revenue from its antibody products, particularly from biotech giant Genentech Inc.
Posts |
COMPANY : PDL BioPharma, Inc.
VIDEO | COMPANIES : PDL BioPharma, Inc.
Shares of three biopharma companies are falling after the FDA revealed a potentially fatal diabetes drug risk, with CNBC...
The NYSE announces a crackdown on insider trading, with Richard Ketchum, NYSE Regulation, Inc. CEO
More Videos
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes